Importantly, in recent years it has been shown that OLs and OPCs are not simply passive targets of damage in MS but can also play active roles in MS inflammation and progression, possessing the ability to present antigen and attract CD4+ and CD8+ T cells that elicit further demyelination (91, 92). Here, CD8A is linked to myeloid sarcoma.